Pennant Investors’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-170,900
Closed -$1.59M 21
2024
Q2
$1.59M Hold
170,900
0.42% 15
2024
Q1
$1.69M Hold
170,900
0.42% 12
2023
Q4
$552K Buy
+170,900
New +$552K 0.12% 14